TS

Torben Straight Nissen

Chief Executive Officer at Repertoire Immune Medicines

Boston, Massachusetts

Overview 

Torben Straight Nissen is an Executive Partner at Flagship Pioneering in Boston, Massachusetts, with a Ph.D. from the Technical University of Denmark. He has held key leadership positions at various biotech and pharmaceutical companies, including Chief Executive Officer at Repertoire Immune Medicines and President at Rubius Therapeutics. Nissen's career highlights include serving as Vice President at Pfizer in various strategic and operational roles, and his current role as an Executive Partner at Flagship Pioneering, where he contributes expertise in project management and leadership within the biotech and pharmaceutical industry.

Work Experience 

  • Executive Partner

    2022 - Current

  • Senior Partner

    2019 - 2023

  • Venture Partner

    2016 - 2019

Flagship Pioneering is a venture capital firm that invests in life sciences and healthcare companies.

  • Chief Executive Officer

    2022

Repertoire Immune Medicines is a clinical stage biotechnology company.

Raised $257,275,890.00 from Invus, PSP Investments, SoftBank Vision Fund, Flagship Pioneering and Alaska Permanent Fund.

  • Founding CEO

    2021

  • Board Member

    2018 - 2021

Ring Therapeutics is a gene therapy company focused on discovering and developing programmable genetic medicines.

Raised $253,500,000.00 from Altitude Life Science Ventures, Flagship Pioneering, UPMC Enterprises, CJ Investment, Partners Investment, T. Rowe Price, Alexandria Venture Investments, Invus and Kyowa Kirin.

  • President

    2016 - 2019

Rubius has developed the technology to grow, genetically engineer and mature long-circulating Red-Cell Therapeutics.

Raised $445,000,000.00 from Flagship Pioneering.

  • Vice President, Strategic Portfolio Management and Planning, Worldwide R&D

    2015 - 2016

  • Head, Strategy, Portfolio and Operations, BioTherapeutics R&D

    2014 - 2015

  • Chief Operating Officer, Centers for Therapeutic Innovation

    2012 - 2014

  • Managing Director & Head of Project and Portfolio Management, Centers for Therapeutic Innovation

    2011 - 2012

Pfizer is a biopharmaceutical company that provides affordable access to safe, effective medicines and health care services.

Raised $32,000,000,000.00 from Starboard Value.

  • Chief Operations Officer

    2008 - 2011

  • President, Biologics and Senior Vice President, moksha8

    2007 - 2008

Moksha8 is a pharmaceutical company providing therapeutics for the treatment of central nervous system and mental health disorders.

Raised $224,071,696.00 from Forest Laboratories.

  • Managing Director

    2005 - 2007

  • Senior Vice President, Global Project Management

    2005 - 2006

  • Vice President, Global Project Management

    2004 - 2005

  • Director, Protein Pharmaceuticals

    2002 - 2004

  • Principle Scientist and Project Leader

    2000 - 2002

  • Principal Scientist and Project Leader

    1999 - 2000

Articles About Torben Straight

Relevant Websites